$CAH Cashflow Statement | Understand Stock

$CAH

$251.54 +$1.97 (0.79%) Close

$CAH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Cash flows from operating activities:
Net earnings
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization
Impairments and (gain)/loss on sale of other investments, net
Equity Method Investment, Other-than-Temporary Impairment
Impairments and (gain)/loss on disposal of assets, net
(Gain)/Loss on sale of equity interest in naviHealth
Loss on early extinguishment of debt
Share-based compensation
Provision for/(benefit from) deferred income taxes
Provision for bad debts
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables
(Increase)/decrease in inventories
Increase in accounts payable
Repurchases of liability-classified units
Other accrued liabilities and operating items, net
Net cash provided by operating activities
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired
Additions to property and equipment
Proceeds from divestitures, net of cash sold
Proceeds from disposal of property and equipment
Purchase of investments
Proceeds from investments
Payments for (Proceeds from) Hedge, Investing Activities
Purchase of short-term time deposits
Proceeds from short-term investment in time deposit
Other investing items, net
Net cash used in investing activities
Cash flows from financing activities:
Net change in short-term borrowings
Proceeds from long-term obligations, net of issuance costs
Purchase of noncontrolling interests
Proceeds from interest rate swap terminations
Reduction of long-term obligations
Net tax proceeds/(withholding) from share-based compensation
Dividends on common shares
Purchase of treasury shares
Net cash provided by/(used in) financing activities

Effect of exchange rates changes on cash and equivalents
Cash reclassified from/(to) assets held for sale
Net increase/(decrease) in cash and equivalents
Cash and equivalents at beginning of period
Cash and equivalents at end of period
Supplemental Information:
Cash payments for interest
Net cash payments for income taxes

Comments